Connect with us

Hi, what are you looking for?

Uncategorized

After-hours movers: GM, Tesla gain on EV charging pact; DocuSign jumps on EPS

© Reuters After-hours movers: GM, Tesla gain on EV charging pact; DocuSign jump on EPS

After-Hours Movers:

Planet Labs PBC (NYSE:) 15% LOWER; reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). came in at $52.7 million versus the consensus estimate of $52.92M. Planet Labs sees Q2 2024 revenue of $53-55M, versus the consensus of $60.7M. Non-GAAP Gross Margin is expected to be in the range of approximately 48% to 49%. Adjusted EBITDA loss is expected to be in the range of approximately ($20)M and ($17)M. Planet Labs sees FY2024 revenue of $225-235M, versus the consensus of $257M.

Braze Inc (NASDAQ:) 8% HIGHER; reported Q1 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18). came in at $101.8M versus the consensus estimate of $98.99M. Braze, Inc. sees Q2 2024 EPS of ($0.13)-($0.14), versus the consensus of ($0.16). Braze, Inc. sees Q2 2024 revenue of $108-109M, versus the consensus of $107.18M. Braze, Inc. sees FY2024 EPS of ($0.51)-($0.55), versus the consensus of ($0.55). Braze, Inc. sees FY2024 revenue of $442.5-446.5M, versus the consensus of $436.43M.

DocuSign (NASDAQ:) 6% HIGHER; reported Q1 EPS of $0.72, $0.17 better than the analyst estimate of $0.55. came in at $661.4M versus the consensus estimate of $641.69M. DocuSign Inc . sees Q2 2024 revenue of $675-679M, versus the consensus of $670.4M. DocuSign Inc. sees FY2024 revenue of $2.713-2.725B, versus the consensus of $2.7B.

Tesla, Inc. (NASDAQ:) 3% HIGHER; GM to use Tesla’s NACS connector design and charging stations.

General Motors (NYSE:) 3% HIGHER; teams with Tesla on EV charging.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

News

Follow Play Earnings CallPlay Earnings Call Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs...